ARMISTICE CAPITAL, LLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 189 filers reported holding PTC THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$137,821,500
+4.7%
6,150,000
+90.0%
2.11%
+10.9%
Q2 2023$131,608,120
-7.1%
3,236,000
+10.7%
1.90%
-6.6%
Q1 2023$141,638,560
+9.3%
2,924,000
-13.9%
2.04%
-9.8%
Q4 2022$129,625,320
-11.0%
3,396,000
+17.1%
2.26%
-10.5%
Q3 2022$145,580,000
+10.3%
2,900,000
-12.0%
2.52%
+9.6%
Q2 2022$132,038,000
+16.6%
3,296,000
+8.6%
2.30%
+5.2%
Q1 2022$113,273,000
+210.1%
3,036,000
+231.0%
2.19%
+266.2%
Q4 2021$36,528,000
-62.2%
917,107
-64.7%
0.60%
-63.4%
Q3 2021$96,597,000
+9.2%
2,596,000
+24.1%
1.64%
+3.3%
Q2 2021$88,429,000
+33.8%
2,092,000
+49.9%
1.58%
+4.3%
Q1 2021$66,101,000
+51.3%
1,396,000
+95.0%
1.52%
+2.2%
Q4 2020$43,697,000
+29.1%
716,000
-1.1%
1.49%
+21.0%
Q3 2020$33,847,000
+33.4%
724,000
+44.8%
1.23%
+10.3%
Q2 2020$25,370,000
-5.2%
500,000
-16.7%
1.11%
-32.7%
Q1 2020$26,766,000
-26.5%
600,000
-20.8%
1.66%
-21.2%
Q4 2019$36,407,000
+691.5%
758,000
+457.4%
2.10%
+588.5%
Q3 2019$4,600,000
-69.4%
136,000
-66.0%
0.30%
-63.0%
Q1 2019$15,056,000
+46.2%
400,000
+33.3%
0.82%
+5.6%
Q4 2018$10,296,000300,0000.78%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Burrage Capital Management LLC 160,372$7,594,0006.15%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 408,000$19,319,0005.11%
RTW INVESTMENTS, LP 5,293,966$250,669,0003.91%
GEORGE KAISER FAMILY FOUNDATION 72,105$9,925,0002.07%
SECTORAL ASSET MANAGEMENT INC 504,928$23,908,0001.81%
Redwood Investments, LLC 385,014$18,230,0001.60%
ARMISTICE CAPITAL, LLC 1,396,000$66,101,0001.52%
Integral Health Asset Management, LLC 100,100$4,740,0001.35%
Sofinnova Investments, Inc. 466,840$22,105,0001.33%
Chubb Ltd 8,180$387,0001.10%
View complete list of PTC THERAPEUTICS INC shareholders